A single-centre real-life experience on effectiveness and safety of dupilumab in adolescents with severe atopic dermatitis in treatment with cyclosporine A

J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e533-e535. doi: 10.1111/jdv.17280. Epub 2021 May 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cyclosporine* / adverse effects
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Injections, Subcutaneous
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab
  • Cyclosporine